000 01357 a2200373 4500
005 20250518024950.0
264 0 _c20200424
008 202004s 0 0 eng d
022 _a1573-0646
024 7 _a10.1007/s10637-019-00744-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTang, Fei
245 0 0 _aPopulation pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumors.
_h[electronic resource]
260 _bInvestigational new drugs
_c12 2019
300 _a1218-1230 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Phytogenic
_xblood
650 0 4 _aCamptothecin
_xanalogs & derivatives
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Biological
650 0 4 _aNeoplasms
_xblood
650 0 4 _aOrganosilicon Compounds
_xblood
700 1 _aTsakalozou, Eleftheria
700 1 _aArnold, Susanne M
700 1 _aNg, Chee M
700 1 _aLeggas, Markos
773 0 _tInvestigational new drugs
_gvol. 37
_gno. 6
_gp. 1218-1230
856 4 0 _uhttps://doi.org/10.1007/s10637-019-00744-0
_zAvailable from publisher's website
999 _c29428052
_d29428052